Cargando…

New Insights into Hormonal Therapies in Uterine Sarcomas

SIMPLE SUMMARY: Uterine sarcomas are rare mesenchymal malignant cancers, and surgery represents the mainstay of treatment for early-stage disease. In metastatic setting, uterine sarcomas’ treatment includes palliative surgery, a metastases resection, chemotherapy and targeted therapy. Hormonal thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maccaroni, Elena, Lunerti, Valentina, Agostinelli, Veronica, Giampieri, Riccardo, Zepponi, Laura, Pagliacci, Alessandra, Berardi, Rossana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870116/ https://www.ncbi.nlm.nih.gov/pubmed/35205669 http://dx.doi.org/10.3390/cancers14040921

Ejemplares similares

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Optimal management of resected gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2018)

Hormonal therapy in uterine sarcomas
por: Zang, Yuqin, et al.
Publicado: (2019)

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021)

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type
por: Maccaroni, Elena, et al.
Publicado: (2021)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
por: Mentrasti, Giulia, et al.
Publicado: (2020)

Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID‐ 19 pandemic
por: Agostinelli, Veronica, et al.
Publicado: (2022)

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase
por: Merloni, Filippo, et al.
Publicado: (2019)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2021)

Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report
por: Ballatore, Z., et al.
Publicado: (2016)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
por: Berardi, Rossana, et al.
Publicado: (2020)

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis
por: Giampieri, Riccardo, et al.
Publicado: (2017)

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows
por: Torniai, Mariangela, et al.
Publicado: (2022)

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
por: Maccaroni, Elena, et al.
Publicado: (2015)

Potential benefit of hormonal therapy for non-uterine soft tissue sarcoma (STS) – a case report and literature review
por: Li, Li, et al.
Publicado: (2013)

Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma
por: Lu, Linghui, et al.
Publicado: (2023)

Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study
por: Liguori, Carolina, et al.
Publicado: (2023)

Uterine sarcoma – current perspectives
por: Benson, Charlotte, et al.
Publicado: (2017)

Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience
por: Pistelli, Mirco, et al.
Publicado: (2021)

Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids
por: Chen, Innie, et al.
Publicado: (2018)

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management
por: Scartozzi, Mario, et al.
Publicado: (2012)

Frequency of uterine sarcomas in patients admitted for uterine fibroid surgery
por: Mettler, Liselotte, et al.
Publicado: (2017)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

Hormone Therapy Reduces Recurrence in Stage II-IV Uterine Low-Grade Endometrial Stromal Sarcomas: A Retrospective Cohort Study
por: Huang, Xiaodi, et al.
Publicado: (2022)

The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas
por: Hou, Hai-Ling, et al.
Publicado: (2015)

Current status of the adjuvant therapy in uterine sarcoma: A literature review
por: Rizzo, Alessandro, et al.
Publicado: (2019)

Undifferentiated uterine sarcoma metastatic to the brain
por: Stofko, Douglas L
Publicado: (2013)

Outcome analysis in patients with uterine sarcoma
por: Yu, Tosol, et al.
Publicado: (2015)

Potential Therapeutic Targets in Uterine Sarcomas
por: Cuppens, Tine, et al.
Publicado: (2015)

Advances in the Preoperative Identification of Uterine Sarcoma
por: Liu, Junxiu, et al.
Publicado: (2022)

Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Correction to: Expectations and psychological issues before genetic counseling: analysis of distress determinant factors
por: Ballatore, Zelmira, et al.
Publicado: (2020)

Uterine sarcoma: almost more tumor than patient
por: Ellis, Laura Burney, et al.
Publicado: (2023)

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
por: Scartozzi, Mario, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ehmslbe2cj43hataqqat4h7j5